ZA962345B - New peptides with immunomodulatory effects - Google Patents

New peptides with immunomodulatory effects

Info

Publication number
ZA962345B
ZA962345B ZA962345A ZA962345A ZA962345B ZA 962345 B ZA962345 B ZA 962345B ZA 962345 A ZA962345 A ZA 962345A ZA 962345 A ZA962345 A ZA 962345A ZA 962345 B ZA962345 B ZA 962345B
Authority
ZA
South Africa
Prior art keywords
immunomodulatory effects
new peptides
peptides
new
immunomodulatory
Prior art date
Application number
ZA962345A
Other languages
English (en)
Inventor
Hakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Saernstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA962345B publication Critical patent/ZA962345B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
ZA962345A 1995-03-24 1996-03-22 New peptides with immunomodulatory effects ZA962345B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501067A SE9501067D0 (sv) 1995-03-24 1995-03-24 New peptides

Publications (1)

Publication Number Publication Date
ZA962345B true ZA962345B (en) 1996-09-25

Family

ID=20397676

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA962345A ZA962345B (en) 1995-03-24 1996-03-22 New peptides with immunomodulatory effects

Country Status (20)

Country Link
US (1) US6228373B1 (xx)
EP (1) EP0785945A1 (xx)
JP (1) JPH10501003A (xx)
AR (1) AR002724A1 (xx)
AU (1) AU5166296A (xx)
BR (1) BR9605890A (xx)
CA (1) CA2189656A1 (xx)
CZ (1) CZ344096A3 (xx)
EE (1) EE9600208A (xx)
HU (1) HUP9603537A3 (xx)
IL (1) IL117615A0 (xx)
IS (1) IS4382A (xx)
NO (1) NO964959L (xx)
NZ (1) NZ304468A (xx)
PL (1) PL317348A1 (xx)
SE (1) SE9501067D0 (xx)
SK (1) SK150196A3 (xx)
TR (1) TR199600932T1 (xx)
WO (1) WO1996030397A1 (xx)
ZA (1) ZA962345B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039023A1 (en) * 1996-04-12 1997-10-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP2002532200A (ja) * 1998-12-21 2002-10-02 イーファオエフ・ハルトマン・アーゲー 感染防止タンポン
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
FR2872042B1 (fr) * 2004-06-29 2006-09-15 Soc Extraction Principes Actif Utilisation d'un dipeptide dimerise en tant qu'agent actif dans ou pour la preparation une composition cosmetique et/ou dermatologique
AP2695A (en) 2005-04-25 2013-07-16 Cadila Pharmaceuticals Ltd Vaccine adjuvants
GB0524884D0 (en) * 2005-12-06 2006-01-11 Syngenta Ltd Improvements in or relating to organic compounds
WO2009140408A2 (en) 2008-05-13 2009-11-19 University Of Kansas Metal abstraction peptide (map) tag and associated methods
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
EP0300031A4 (en) 1987-01-28 1990-05-14 Ortho Pharma Corp IMMUNE SUPPRESSIVE PEPTIDES AND METHOD FOR THEIR USE.
FR2622700B1 (fr) * 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
EP0341603A3 (en) 1988-05-09 1990-07-04 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Medicinal preparations containing a history of cystine
AU655599B2 (en) 1990-09-11 1995-01-05 Institute For Child Health Research Cloning and sequencing of allergens of dermatophagoides (house dust mite)
AU2296792A (en) 1991-06-28 1993-01-25 Corvas International, Inc. Novel inhibitors of platelet aggregation
KR100260342B1 (ko) 1991-10-16 2000-07-01 스타세이 엘. 첸링 더마토파고이드로 부터 유래된 알레르겐의 t세포 에피토프
KR960700739A (ko) * 1993-03-05 1996-02-24 카린 이스텀 Hla-a2. 1 결합 펩티드 및 그의 용도(hla-a2. 1 binding peptides and their uses)
IL106214A (en) 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
BR9508243A (pt) 1994-07-05 1997-10-21 Steeno Res Group As Imunomoduladores
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
EE9600208A (et) 1997-06-16
CZ344096A3 (en) 1997-05-14
US6228373B1 (en) 2001-05-08
PL317348A1 (en) 1997-04-01
HU9603537D0 (en) 1997-02-28
JPH10501003A (ja) 1998-01-27
AU5166296A (en) 1996-10-16
NZ304468A (en) 1999-02-25
WO1996030397A1 (en) 1996-10-03
IL117615A0 (en) 1996-07-23
CA2189656A1 (en) 1996-10-03
AR002724A1 (es) 1998-04-29
BR9605890A (pt) 1997-09-23
SK150196A3 (en) 1997-06-04
HUP9603537A2 (en) 1997-08-28
SE9501067D0 (sv) 1995-03-24
TR199600932T1 (tr) 1997-03-21
HUP9603537A3 (en) 1998-03-02
NO964959D0 (no) 1996-11-21
EP0785945A1 (en) 1997-07-30
IS4382A (is) 1996-11-08
NO964959L (no) 1996-11-21

Similar Documents

Publication Publication Date Title
HUP9901455A3 (en) Somatostatin peptides
IL115509A0 (en) New peptides with immunomodulatory effects
EP0765165A4 (en) PREVENTED PEPTIDES
IL108169A0 (en) New peptides
EP0804469A4 (en) NEW PEPTIDE
GB9500601D0 (en) Modified peptides
PL318017A1 (en) Peptides
ZA962345B (en) New peptides with immunomodulatory effects
EP0746565A4 (en) PEPTIDES RELATED TO BOMBESIN
GB9425380D0 (en) Peptides
EP0850950A4 (en) PEPTIDE DERIVATIVES
EP0861849A4 (en) PEPTIDE DERIVATIVES
GB9526613D0 (en) Sequence
IL124342A0 (en) Antineoplastic peptides
GB9519511D0 (en) Peptides
GB9425381D0 (en) Peptides
GB9613705D0 (en) Novel peptides
GB9511092D0 (en) Peptides
GB9505924D0 (en) Peptide
GB9507041D0 (en) Cyclic peptides
GB9519218D0 (en) Peptide factor
ZA956331B (en) Peptides
GB9421408D0 (en) Peptides
GB9514835D0 (en) Polypeptide
GB9514580D0 (en) Polypeptide